Biotechnology · Healthcare
Chairman, Board Member
2024-04-01–present
Chairman
Autolus Therapeutics plc (AUTL)Board Member
Autolus Therapeutics plc (AUTL)Equibles does not estimate personal net worth.
Get an email with a short summary when Autolus Therapeutics plc publishes a filing, an earnings call transcript or a press release.
Get AUTL alertsMichael W. Bonney is recorded as Chairman and Board Member at Autolus Therapeutics plc (AUTL) since April 1, 2024. Autolus Therapeutics plc reported in an 8-K filed April 1, 2024 that Michael W. Bonney was appointed Class II director, effective April 1, 2024. Autolus Therapeutics plc reported in an 8-K filed April 1, 2024 that Michael W. Bonney was appointed Chair of the Board, effective April 1, 2024. Autolus Therapeutics plc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Autolus Therapeutics plc includes Patrick McIlvenny (Chief Accounting Officer), Rob Dolski (Chief Accounting Officer), Elisabeth ("Lis") Leiderman, M.D. (Board Member) and 3 others.
“On March 26, 2024, the Board, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Michael W. (“Mike”) Bonney to serve as a Class II director of the Company and as Chair of the Board, effective April 1, 2024.”
“On March 26, 2024, the Board, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Michael W. (“Mike”) Bonney to serve as a Class II director of the Company and as Chair of the Board, effective April 1, 2024.”
2024-04-01–present
2024-04-01–present
Biotechnology · Healthcare
Chairman, Board Member
2024-04-01–present